glp-1 blindness Lawsuits claiming Ozempic, other GLP-1s led to become second mass litigation over the drugs GLP-1 Agonists—commonly used for weight

Recent advances in nanotechnology have yielded multifunctional platforms incorporating GSH-responsive linkages, redox-active metals, and prodrug designs with strong promise for targeted delivery and theranostics

This tension between established regulatory medicine and the multibillion-dollar wellness industry was on full display throughout the hearings

During treatment, your provider may monitor: IGF-1 levels glucose and insulin response cholesterol markers liver function kidney function thyroid markers sex hormones blood pressure symptom changes sleep quality energy levels appetite recovery speed body composition skin quality workout performance side effects Monitoring allows your provider to adjust the dosage, change the treatment timeline, pause therapy if needed, or switch to a better-suited peptide based on how your body responds

Molecules (2019) 24(8):1583